Get Premium to unlock powerful stock data
XSWX:NOVN (Switzerland)  
Novartis AG logo

Novartis AG

CHF 81.19 (+0.06%) Jun 29
P/E:
8.22
P/B:
3.14
Market Cap:
CHF 179.64B ($ 187.28B)
Enterprise V:
CHF 191.63B ($ 199.78B)
Volume:
3.94M
Avg Vol (2M):
4.42M
Also Trade In:
Volume:
3.94M
Market Cap CHF:
179.64B
Market Cap $:
187.28B
PE Ratio:
8.22
Avg Vol (2-Month):
4.42M
Enterprise Value CHF:
191.63B
Enterprise Value $:
199.78B
PB Ratio:
3.14
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download Tutorials

Business Description

Description
Novartis AG develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The firm sells its products globally, with the United States representing close to one third of total revenue.

Financials (Next Earnings Date:2022-07-19)

XSWX:NOVN's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil CHF) 48,766.454
EPS (TTM) (CHF) 9.876
Beta 1.11
Volatility % 17.56
14-Day RSI 43.81
14-Day ATR (CHF) 1.302503
20-Day SMA (CHF) 82.0615
12-1 Month Momentum % 3.02
52-Week Range (CHF) 72.84 - 88.42
Shares Outstanding (Mil) 2,212.6

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 8
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Novartis AG Filings

Document Form Filing Date
No Filing Data